Intel, insight and opinions from SEND Specialist (Nerd), Marc Ellison

Welcome to Sensible SEND 

We hope you’ll bookmark the blog and check back often. Look for new posts every other Wednesday offering insights and expert opinions to help you navigate the challenges and opportunities that arise from the SEND standard.

SEND in 2023

Being the first post of the year, I thought it would be good to consider what the year ahead looks like for the world of SEND. The obvious place to start is looking at the standards that are going to become required by the FDA for submission. March will see SEND 3.1 become required for…

Read more

So, was SEND Sensible in 2022?

Greetings of the season everyone! As this will be my last post of the year, I thought it would be interesting to look back at a few of the topics featured in the blog during 2022. Back in January I was hoping to see the publication of the SEND standards for juvenile toxicology (SENDIG-DART 1.2)…

Read more

Nervous System Tests and SEND: what’s going on?

There have been rumors of a proposed Nervous System domain (NV) for many years, yet still nothing has been published and it’s not listed in the content for SEND 4.0. So, just what is going on? At the recent joint FDA and CDISC SEND meeting, the full scope of SEND 4.0 was presented, and so…

Read more